| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |